NSAIDs--should every prescription carry a government health warning?
作者信息
Cockel R
出版信息
Gut. 1987 May;28(5):515-8. doi: 10.1136/gut.28.5.515.
Abstract
摘要
相似文献
1
NSAIDs--should every prescription carry a government health warning?非甾体抗炎药——每张处方都应附带政府健康警告吗？
Gut. 1987 May;28(5):515-8. doi: 10.1136/gut.28.5.515.
2
NSAIDs without a prescription: over-the-counter access, under-counted risks.
Am J Gastroenterol. 2002 Sep;97(9):2159-61. doi: 10.1111/j.1572-0241.2002.05965.x.
3
NSAIDs: is over-the-counter the best?
J Am Geriatr Soc. 1990 Aug;38(8):956. doi: 10.1111/j.1532-5415.1990.tb05717.x.
4
[Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Part II].[临床指南《非甾体抗炎药（NSAIDs）在临床实践中的合理使用》。第二部分]
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(5):94-99. doi: 10.17116/jnevro20151155194-99.
5
Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.非处方非甾体抗炎药与胃肠道症状风险
Am J Gastroenterol. 2003 May;98(5):1203-4; author reply 1204. doi: 10.1111/j.1572-0241.2003.07443.x.
6
Non-steroidal anti-inflammatory drugs.非甾体抗炎药。
Br J Rheumatol. 1993 Jun;32 Suppl 4:35-8. doi: 10.1093/rheumatology/32.suppl_4.35.
7
Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.合理使用非甾体抗炎药和胃保护剂的评估；利用门诊处方模式进行关联规则数据挖掘。
BMC Med Inform Decis Mak. 2017 Jul 4;17(1):96. doi: 10.1186/s12911-017-0496-3.
8
Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.使用非选择性非甾体抗炎药或昔布类药物的老年门诊患者的上消化道症状及治疗
Aliment Pharmacol Ther. 2005 Jul 15;22(2):147-55. doi: 10.1111/j.1365-2036.2005.02537.x.
9
Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.非处方非甾体抗炎药与胃肠道症状风险
Am J Gastroenterol. 2002 Sep;97(9):2215-9. doi: 10.1111/j.1572-0241.2002.05974.x.
10
What did the questionnaire say?调查问卷上怎么说的？
Br J Gen Pract. 2014 Jun;64(623):276. doi: 10.3399/bjgp14X679981.
引用本文的文献
1
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.米索前列醇：其用作预防非甾体抗炎药引起的胃十二指肠损伤的药物经济学
Pharmacoeconomics. 1993 Feb;3(2):140-71. doi: 10.2165/00019053-199303020-00007.
2
Prescribing policy for antiulcer treatment in the elderly.老年人抗溃疡治疗的处方政策。
Drugs Aging. 1993 Jul-Aug;3(4):308-19. doi: 10.2165/00002512-199303040-00002.
3
Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.长期联合使用米索前列醇与非甾体抗炎药的效果：一项组织学研究。
Gut. 1995 Aug;37(2):195-8. doi: 10.1136/gut.37.2.195.
4
Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.预防非甾体抗炎药所致胃十二指肠损伤：雷尼替丁对照试验
BMJ. 1988 Oct 22;297(6655):1017-21. doi: 10.1136/bmj.297.6655.1017.
5
Do nizatidine and cimetidine interact with ibuprofen?
Eur J Clin Pharmacol. 1988;35(1):85-8. doi: 10.1007/BF00555513.
6
Clinical pharmacology and therapeutics.临床药理学与治疗学
Postgrad Med J. 1990 Mar;66(773):166-85. doi: 10.1136/pgmj.66.773.166.
7
The problems and pitfalls of NSAID therapy in the elderly (Part II).老年人非甾体抗炎药治疗的问题与陷阱（第二部分）
Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005.
8
Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications.
Drug Saf. 1992 Mar-Apr;7(2):86-105. doi: 10.2165/00002018-199207020-00002.
9
Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy.幽门螺杆菌：非甾体抗炎药所致胃病的一个风险和严重程度因素。
Gut. 1992 Dec;33(12):1608-11. doi: 10.1136/gut.33.12.1608.
10
General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions.泰赛德和法夫地区全科医生对非甾体抗炎药的使用情况。
J R Soc Med. 1992 Aug;85(8):442-5. doi: 10.1177/014107689208500806.
本文引用的文献
1
Non-steroidal anti-inflammatory drugs and benign oesophageal stricture.非甾体抗炎药与良性食管狭窄
Br Med J (Clin Res Ed). 1982 Jul 17;285(6336):167-8. doi: 10.1136/bmj.285.6336.167.
2
Intestinal perforation associated with osmotic slow release indomethacin capsules.与渗透性缓释吲哚美辛胶囊相关的肠穿孔
Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1671-2. doi: 10.1136/bmj.287.6406.1671-a.
3
Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.因小肠或大肠穿孔及出血入院的患者使用抗炎药物的情况。
Br Med J (Clin Res Ed). 1985 Feb 2;290(6465):347-9. doi: 10.1136/bmj.290.6465.347.
4
Two cheers for NSAIDs.为非甾体抗炎药喝彩两声。
Gut. 1986 Nov;27(11):1287-91. doi: 10.1136/gut.27.11.1287.
5
Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.非甾体抗炎药对风湿性疾病患者消化性溃疡治疗影响的随机研究。
Gut. 1987 Feb;28(2):226-9. doi: 10.1136/gut.28.2.226.
6
Rising frequency of ulcer perforation in elderly people in the United Kingdom.英国老年人溃疡穿孔发生率上升。
Lancet. 1986 Mar 1;1(8479):489-92. doi: 10.1016/s0140-6736(86)92940-5.
Zotero 插件